Skip to content

Clinical trials

Completed Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Status: Completed Clear all

190 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200111
200212
200310
200414
200513
20068
20075
20086
20096
201010
20114
20124
20139
20143
20153
20171
20183
20193
20202
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed190

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
Fred Hutchinson Cancer Center16
Memorial Sloan Kettering Cancer Center10
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins10
Case Comprehensive Cancer Center8
M.D. Anderson Cancer Center5
National Heart, Lung, and Blood Institute (NHLBI)5
Roswell Park Cancer Institute5
University of California, San Francisco5
Masonic Cancer Center, University of Minnesota4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts190
Myelodysplastic Syndromes114
Leukemia108
Leukemia, Myeloid, Acute104
Leukemia, Myelomonocytic, Chronic96
Precursor Cell Lymphoblastic Leukemia-Lymphoma78
Myeloproliferative Disorders60
Congenital Abnormalities57
Anemia, Refractory54
Leukemia, Lymphocytic, Chronic, B-Cell47

Trials

Showing 1 to 25 of 190. Each trial links to its page on Pharma Observatory.

90 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.